Company page
Irlab Therapeutics Ab Class A
Irlab Therapeutics AB Class A is a public company listed on the Swedish market under the ticker IRLAB_A. The company has a market capitalization of approximately 20.06 million USD. Irlab focuses on developing innovative treatments for neurological diseases.
- Ticker
- IRLAB_A:OMXSTO
- Asset type
- Stock
- Market cap
- $24.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK